The following data is part of a premarket notification filed by Becton Dickinson & Co. with the FDA for Bbl Chromagar Mrsa Ii.
| Device ID | K092767 |
| 510k Number | K092767 |
| Device Name: | BBL CHROMAGAR MRSA II |
| Classification | Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar |
| Applicant | BECTON DICKINSON & CO. 7 LOVETON CIR. Sparks, MD 21152 |
| Contact | Paul Swift |
| Correspondent | Paul Swift BECTON DICKINSON & CO. 7 LOVETON CIR. Sparks, MD 21152 |
| Product Code | JSO |
| CFR Regulation Number | 866.1700 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2009-09-09 |
| Decision Date | 2010-08-20 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 30382902153598 | K092767 | 000 |
| 30382902152287 | K092767 | 000 |
| 30382902152294 | K092767 | 000 |
| 30382902154212 | K092767 | 000 |